Ectin Research AB (XSAT:ECTIN B) Other Income (Expense) : kr-8.98 Mil (TTM As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Ectin Research AB Other Income (Expense)?

Ectin Research AB's other income expense for the Ectin Research AB's pretax income for the three months ended in Mar. 2024 was kr0.00 Mil. Its other income expense for the trailing twelve months (TTM) ended in Mar. 2024 was kr-8.98 Mil.

Ectin Research AB Other Income (Expense) Historical Data

The historical data trend for Ectin Research AB's Other Income (Expense) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ectin Research AB Other Income (Expense) Chart

Ectin Research AB Annual Data

Trend

Aug19

Aug20

Dec22

Dec23

Other Income (Expense)

-8.98

Ectin Research AB Quarterly Data
	Aug19	Aug20	Mar21	Sep21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Income (Expense)	Get a 7-Day Free Trial								-	-	-	-8.98	-

Ectin Research AB Other Income (Expense) Calculation

Other income expense includes minority interest. Minority interest is a significant but non-controlling ownership of less than 50% of a company's voting shares by either an investor or another company.

Other Income (Expense) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-8.98 Mil.

Ectin Research AB (XSAT:ECTIN B) Other Income (Expense) Explanation

Minority interest is reported on the consolidated income statement as a share of profit belonging to minority shareholders.

Ectin Research AB (XSAT:ECTIN B) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ectin Research AB (XSAT:ECTIN B) » Definitions » Other Income (Expense)

Comparable Companies

Traded in Other Exchanges

N/A

Address

Pepparedsleden 1, Molndal, SWE, 431 83

Website

https://www.ectinresearch.com

Ectin Research AB is a pharmaceutical company developing a novel treatment that eliminates cancer tumors. Its drug candidate MFA-370 engages in the treatment of metastatic bladder cancer, and has also shown potential in other cancers such as breast, colorectal and prostate cancer cells.

Ectin Research AB (XSAT:ECTIN B) Headlines

No Headlines